Status: current, Defined. Date: 30-Apr 2017. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3915151000168116 | Carvedilol (Watson) (carvedilol 3.125 mg) tablet (trade product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 3915161000168119 | Carvedilol (Watson) 3.125 mg tablet | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Carvedilol (Watson) 3.125 mg tablet | has manufactured dose form | tablet | true | Inferred relationship | Some | ||
| Carvedilol (Watson) 3.125 mg tablet | Is a | carvedilol 3.125 mg tablet | true | Inferred relationship | Some | ||
| Carvedilol (Watson) 3.125 mg tablet | Is a | trade product unit of use | true | Inferred relationship | Some | ||
| Carvedilol (Watson) 3.125 mg tablet | Is a | Carvedilol (Watson) | true | Inferred relationship | Some | ||
| Carvedilol (Watson) 3.125 mg tablet | has manufactured dose form | uncoated tablet | false | Inferred relationship | Some | ||
| Carvedilol (Watson) 3.125 mg tablet | has unit of use | tablet | true | Inferred relationship | Some | 1307543597 | |
| Carvedilol (Watson) 3.125 mg tablet | has Australian BoSS | carvedilol | true | Inferred relationship | Some | 1307543596 | |
| Carvedilol (Watson) 3.125 mg tablet | has intended active ingredient | carvedilol | true | Inferred relationship | Some | 1307543596 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Carvedilol (Watson) 3.125 mg tablet, 30, blister pack | has TPUU | True | Carvedilol (Watson) 3.125 mg tablet | Inferred relationship | Some | 1 |
| Carvedilol (Watson) 3.125 mg tablet, 30 | has TPUU | True | Carvedilol (Watson) 3.125 mg tablet | Inferred relationship | Some | 1 |
Reference Sets
Trade product unit of use reference set
FHIR